- Morin, P., Bédard, J. and Lefebvre, G.M. (1990) Certain aspects of the pH dependence of triggering in Bacillus megaterium spores. Current Microbiology 21, 349-354.
- Morin, P.J. and Gilmore, T.D. (1992) The C-terminus of the NF-kB p50 precursor and an IkB isoform contain transcription activation domains. Nucleic Acids Res. 20, 2453-2458.[Abs]
- Morin, P.J., Subramanian, G.S. and Gilmore, T.D. (1992) AAT1, a gene encoding a mitochondrial aspartate aminotransferase in Saccharomyces cerevisiae. Biochimica et Biophysica Acta 1171, 211-214.[Abs]
- Morin, P.J., Subramanian, G.S. and Gilmore, T.D. (1993) GAL4-IkBa and GAL4-IkBg activate transcription by different mechanisms. Nucleic Acids Res. 21, 2157-2163.[Abs]
- Gilmore, T.D. and Morin, P.J. (1993) The IkB proteins: members of a multifunctional family. Trends in Genetics 9, 427-433.[Abs]
- Morin, P.J., Downs, J.A., Snodgrass, A. M. and Gilmore, T.D. (1995) Genetic analysis of growth inhibition by GAL4-IkB-a in Saccharomycescerevisiae. Cell Growth and Differentiation 6, 789-798.[Abs]
- Morin, P.J., Vogelstein, B. and Kinzler, K.W. (1996) Apoptosis and APC in colorectal tumorigenesis. Proc. Natl. Acad. Sci. USA 93, 7950-7954.[Abs]
- Huang, J., Papadopoulos, N., McKinley, A.J., Farrington, S.M., Curtis, L.J., Wyllie, A.H., Zheng, S., Willson, J.K.V., Markowitz, S.D., Morin, P.J., Kinzler, K.W., Vogelstein, B. and Dunlop, M.G. (1996) APC mutations in colorectal tumors with mismatch repair deficiency. Proc. Natl. Acad. Sci. USA 93, 9049-9054.[Abs]
- Korinek, V., Barker, N., Morin, P.J., van Wichen, D., de Weger, R., Kinzler, K.W., Vogelstein, B. and Clevers, H. (1997) Constitutive transcriptional activation by a b-catenin/Tcf complex in APC -/- colon carcinoma. Science 275, 1784-1787.[Abs]
- Morin, P.J., Sparks, A.B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B. and Kinzler, K.W. (1997) Activation of b-catenin-Tcf signaling in colon cancer by mutations in b-catenin or APC. Science 275, 1787-1790.[Abs]
- Chan*, T., Morin*, P.J., Vogelstein, B. and Kinzler, K.W. (1998) Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc. Natl. Acad. Sci. USA 95, 681-686.[Abs] *These authors contributed equally to this work.
- Sparks*, A.B., Morin*, P.J., Vogelstein, B. and Kinzler, K.W. (1998). Mutational analysis of the APC/b-catenin/Tcf pathway in colorectal cancer. Cancer Research 58, 1130-1134.[Abs] *These authors contributed equally to this work.
- He, T.-C., Sparks, A.B., Rago, C., Hermeking, H., Zawel, L., da Costa L.T., Morin, P.J., Vogelstein, B. and Kinzler, K.W. (1998) Identification of c-MYC as a target of the APC pathway. Science 281, 1509-1512.[Abs]
- Lin H., Huber R., Schlessinger, D and Morin, P.J. (1999) Frequent silencing of GPC3 in ovarian cancer cell lines. Cancer Res. 59, 807-810.[Abs]
- da Costa, L.T., He, T.-C., Yu, J., Sparks, A.B., Morin, P.J., Polyak, K., Laken, S., Vogelstein, B. and Kinzler, K.W. (1999) CDX2 is mutated in a colorectal cancer with normal APC/b-catenin signaling. Oncogene. 18, 5010-5014.[Abs]
- Barker, N., Morin, P.J. and Clevers H. (1999) The Yang-Yang of TCF/b-catenin signaling. In: G.F. Vande Woude and G. Klein (Eds.) Advances in Cancer Research. Academic Press, San Diego, 1-24.
- Furlong, M.T., Hough, C.D., Sherman-Baust, C.A., Pizer, E.S. and Morin, P.J. (1999) Evidence that ovarian cancer cell line SW626 may be of colonic origin. J. Natl. Cancer Inst. 91, 1327-1328.[Abs]
- Lal, A., Lash, A.E., Altschul, A.F., Velculescu, V.E., Zhang, L., McLendon, R.E., Marra, M.A., Prange, C., Morin, P.J., Papadopoulos, N., Vogelstein B., Kinzler, K.W., Strausberg, R.L., and Riggins, G.J. (1999) A public database for quantitative gene expression analysis in human cancers. Cancer Res. 59, 5403-5407.[Abs]
- Morin, P.J. (1999) b-catenin signaling and cancer. BioEssays 21, 1021-1030.[Abs]
- Furlong, M.T., and Morin, P.J. (2000) Rare activation of the TCF/b-catenin pathway in ovarian cancer. Gynecological Oncology 77, 97-104.[Abs]
- Lin, H., Pizer, E.S. and Morin, P.J. (2000) A frequent deletion polymorphism on chromosome
22q13 identified by representational difference analysis of ovarian cancer. Genomics 69, 391-394.[Abs]
- Hough, C.D., Sherman-Baust, C.A., Pizer, E.S., Montz, F.J., Im, D.D., Rosenshein, N.B., Cho, K.R., Riggins, G.J. and Morin, P.J. (2000) Large-scale serial analysis of gene expression reveals gene differentially expressed in ovarian cancer. Cancer Res. 60(22), 6281-6287.[Abs]
- Sasaki, C.Y., Lin H.J. Morin, P.J. and Longo, D.L. (2000) Truncation of the extracellular region abrogates cell contact but retains the growth-suppressive activity of E-cadherin. Cancer Res. 60(24), 7057-7065.[Abs]
- Hough, C.D., Cho K.R. and Morin, P.J. (2001) Analysis of genes highly overexpressed in ovarian cancer by real-time RT-PCR. Cancer Res. 61, 3869-3876. [Abs]
- Lin, H. and Morin, P.J. (2001) A novel homozygous deletion at chromosomal band 6q27 in an ovarian cancer cell line delineates the position of a putative tumor suppressor gene. Cancer Lett. 173, 63-70. [Abs]
- Morin, P.J. (2002) APC/b-catenin pathway. In Encyclopedic reference of Cancer Manfred Schwab, editor. Springer-Verlag, Heidelberg. 70-73.
- Morin, P.J. and Pizer, E. (2002) Ovarian Cancer. In Encyclopedic reference of Cancer Manfred Schwab, editor. Springer-Verlag, Heidelberg. 654-656.
- Caldwell, M.C., Hough, C.D., Furer, S., Morin, P.J. and Gorospe, M. (2002) Serial Analysis of gene expression in renal carcinoma cells reveals VHL-dependent sensitivity to TNFa cytotoxicity. Oncogene 21, 929-936. [Abs]
- Sawiris, G.P., Sherman-Baust, C.A., Becker, K.G., Cheadle, C., Teichberg, D., Morin, P.J. (2002) The Ovachip, Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer. Cancer Research, 62, 2923-2928. [Abs] -- [Ovachip Gene List (excel)]
- Riggins, G.J. and Morin P.J. (2002) Gene expression profiling in Cancer. In: The Genetic Basis of Human Cancer, Vogelstein B. and Kinzler K.W. Eds. McGraw Hill, New York. 131-141
- Boon, K., Osorio, E.C., Greenhut, S.F., Schaefer, C.F., Shoemaker, J., Polyak, K., Morin, P.J., Buetow, K.H., Strausberg, R.L., De Souza, S.J., Riggins, G.J. (2002) An anatomy of normal and malignant gene expression. Proc. Natl. Acad. Sci. USA 99(17), 11287-11292. [Abs]
- Yang, Y.A., Han, W.F., Morin, P.J., Chrest, F.J., Pizer, E.S. (2002) Activation of fatty acid synthesis during neoplasic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Exp. Cell Res. 279(1), 80-90. [Abs]
- Morin, P.J. (2002) Renal cell carcinoma: taking care of business. Cancer Biol. Ther. 1(5), 537-538.
- Yang, Y.A., Morin, P.J., Han, W.F., Chen, T., Bornman, D.M., Gabrielson, E.W., Pizer, E.S. (2003) Regulation of fatty acid synthase expression in breast cancer by sterol regulatory element binding protein-1c.Exp. Cell Res. 282(2), 132-137. [Abs]
- Wu, S., Morin, P.J., Maouyo, D., Sears, C.L. (2003) Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology. 124(2), 392-400. [Abs]
- Morin, P.J., Weeraratna, A.T. (2003) Wnt signaling in human cancer. Cancer Treat Res. 115, 169-187.
- Morin, P.J., Weeraratna, A.T. (2003) The APC tumor suppressor pathway. Methods Mol. Biol. 222, 21-40.
- Sherman-Baust, C.A., Weeraratna, A.T., Rangel, L.B., Pizer, E.S., Cho, K.R., Schwartz, D.R., Shock, T., Morin, P.J. (2003) Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells. Cancer Cell. 3(4), 377-386. [Abs]
- Rangel, L.B., Agarwal, R., D'Souza, T., Pizer, E.S., Alo, P.L., Lancaster, W.D., Gregoire, L., Schwartz, D.R., Cho, K.R., Morin, P.J. (2003) Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin. Cancer Res. 9(7), 2567-2575. [Abs]
- Buckhaults, P., Zhang, Z., Chen, Y.C., Wang, T.L., St Croix, B., Saha, S., Bardelli, A., Morin, P.J., Polyak, K., Hruban, R.H., Velculescu, V.E., Shih, I-M. (2003) Identifying tumor origin using a gene expression-based classification map. Cancer Res. 63(14), 4144-4149. [Abs]
- Morin, P.J. (2003) Drug resistance and the microenvironment: nature and nurture. Drug Resist. Updat.6(4), 169-172. [Abs]
- Rangel, L.B., Sherman-Baust, C.A., Wernyj, R.P., Schwartz, D.R., Cho, K.R., Morin, P.J. (2003) Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression. Oncogene. 22(46), 7225-7232. [Abs]
- Weeraratna, A.T., Becker, D., Carr, K.M., Duray, P.H., Rosenblatt, K.P., Yang, S., Chen, Y., Bittner, M., Strausberg, R.L., Riggins, G.J., Wagner, U., Kallioniemi, O.P., Trent, J.M., Morin, P.J., Meltzer, P.S. (2004) Generation and analysis of melanoma SAGE libraries: SAGE advice on the melamona transcriptome. Oncogene. 18(23), 2264-2274. [Abs]
- Rangel, L.B., Agarwal, R., Sherman-Baust, C.A., de Mello-Coelho, V., Pizer, E.S., Ji, H., Taub, D.D., Morin, P.J. (2004) Anomalous expression of the HLA-DR a and b chains in ovarian and other cancer. Cancer Biol. Ther. 3(10). [Abs]
- Wernyj, R.P., Morin, P.J. (2004) Molecular mechanisms of platinum resistance: still searching for the Achilles' heel. Drug Resist. Updat. 7(4-5), 227-232. [Abs]
|
